Net sales and operating profit rose year on year, leading to an upward revision of full-year forecasts. Strong performance in Fine Chemicals and Life Science offset declines in Sustainability, with robust overseas sales and continued capital policy execution.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.